-
Mashup Score: 0
Thomas R. Collins is a medical journalist based in West Palm Beach, Florida. Anemia and hypertension were the two modifiable risk factors most closely related to anticoagulant-associated bleeding risk in patients with cancer, according to findings from a large database analysis that will be presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition. The study suggests that eliminating these and other risk factors that are within the patient’s control could substantially
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
#Anemia and #hypertension were the modifiable risk factors most closely related to #anticoagulant-associated #bleeding risk in patients with #cancer, and the elimination of both brought a ~19% reduction in the probability of bleeding after one year: https://t.co/CxIqPrzZmN #ASH24